Avecho Biotechnology Ltd - A positive Phase III interim analysis
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company currently focused on a CBD (Cannabidiol) soft-gel capsule for insomnia. It...
101 Views
Avecho Biotechnology Ltd - Phase III interim analysis due June 2026
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM...
206 Views
Aussie Healthcare Daily: 4 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
492 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
6.1k Views
Avecho Biotechnology Ltd - Waking the sleeping giant
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM...
271 Views
No more insights